PhRMA targets WHO, WIPO, WTO, UNDP, UNCTAD, Unitaid, and WTO in comments to the USTR’s Special 301 report for 2022
On 13 December 2021, the Office of United States Trade Representative (USTR) posted the following request for public comment in relation to its 2022 Special 301 Review: Identification of Countries Under Section 182 of the Trade Act of 1974 noting… Continue Reading